Heart failure & cardiomyopathies

Prognosis of cardiac resynchronization therapy (CRT)-treated and CRT-untreated unselected population with left bundle branch block (LBBB) in Stockholm County

EuropacePublished Retrospective cohort study

Authors' conclusion

In an unselected LBBB population, CRT is underused but of great value for HF patients.

Study context

Population
Unselected patients with LBBB and QRS > 150 ms, Stockholm County (central electrocardiogram (ECG) database and national registers)1,053 with class I CRT indication
Participants
5,359 patients
Exposure
CRT vs no CRT
Outcome
Death, CV death and HF hospitalization according to CRT use
Methodological detailsregistry-based, unselected real-world population, Median age 76 years, 36% female
  • Registry-based
  • Unselected real-world population
  • Median age 76 years, 36% female

Main finding

As reported in the abstract

Outcomes with CRT among patients with class I indication for CRT
CRT vs No CRTHazard ratio (95% CI)
Death
0.45(0.36–0.57)
CV death
0.47(0.35–0.63)
HF hospitalization
0.56(0.48–0.66)
CRT received among patients with class I indication
60%
Median delay to CRT
137 days

Observational data: associations, not effects.

Further findings

Heart failure (HF) history and incident HF

Previous history of HF at index ECG
41%
Developed HF
27%

Predictors of CRT use

Age over 75 years, dementia and COPD predicted CRT non-use
Having a pacing/defibrillator device independently predicted CRT use

Original publication

Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County. Europace. Published 5 July 2023. doi:10.1093/europace/euad192

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.